文献速递神经儿科影像技术与安全MR

儿童肿瘤影像生物标志物与影像组学:PRIMAGE项目视角

Imaging biomarkers and radiomics in pediatric oncology: a view from the PRIMAGE (PRedictive In silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers) project.
PubMed 文献 · Pediatr Radiol · 2023-09-25

本文综述PRIMAGE项目在儿童肿瘤中开发影像生物标志物的实践。该项目为欧洲多中心研究,针对神经母细胞瘤和弥漫性内生性脑桥胶质瘤,构建整合影像、临床与分子数据的开放云平台及人工智能模型。工作流包括MR图像协调与配准、肿瘤自动检测分割(独立验证集Dice相似系数0.997)及影像组学特征提取,平台正整合入欧洲癌症影像联合会(EUCAIM)。

要点

  • PRIMAGE项目针对神经母细胞瘤和弥漫性内生性脑桥胶质瘤开发影像衍生人工智能决策支持工具。
  • 肿瘤自动分割工具在独立验证集Dice相似系数为0.997,与人工分割变异性相容。
  • 平台整合影像、临床与分子数据及可视化分析工具,并正整合入EUCAIM。

核心结论

  • PRIMAGE项目通过标准化数据处理分析工作流、MR图像协调与配准、肿瘤自动检测分割、影像组学与深度特征提取,并将可重复的影像定量特征与临床分子数据整合,构建了面向神经母细胞瘤和弥漫性内生性脑桥胶质瘤的临床决策辅助系统。

研究设计与样本

  • 综述,介绍欧洲多中心研究项目PRIMAGE的实践开发;该项目创建开放云平台,整合影像、临床和分子数据及人工智能模型,并实施标准化数据处理与分析工作流。

诊断标准与关键数值

  • 肿瘤自动检测与分割工具在独立验证数据集获得的Dice相似系数为0.997,提示与人工分割变异性相容。

临床应用与阅片要点

  • 工作流包含MR图像协调与配准,随后训练并内部验证肿瘤自动检测与分割工具。
  • 提取影像组学与深度特征并与临床终点相关,再将可重复且相关的影像定量特征与临床和分子数据整合以丰富预测模型和可视化分析工具。
  • PRIMAGE数据存储库与平台正整合入欧洲癌症影像联合会(EUCAIM)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

This review paper presents the practical development of imaging biomarkers in the scope of the PRIMAGE (PRedictive In silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers) project, as a noninvasive and reliable way to improve the diagnosis and prognosis in pediatric oncology. The PRIMAGE project is a European multi-center research initiative that focuses on developing medical imaging-derived artificial intelligence (AI) solutions designed to enhance overall management and decision-making for two types of pediatric cancer: neuroblastoma and diffuse intrinsic pontine glioma. To allow this, the PRIMAGE project has created an open-cloud platform that combines imaging, clinical, and molecular data together with AI models developed from this data, creating a comprehensive decision support environment for clinicians managing patients with these two cancers. In order to achieve this, a standardized data processing and analysis workflow was implemented to generate robust and reliable predictions for different clinical endpoints. Magnetic resonance (MR) image harmonization and registration was performed as part of the workflow. Subsequently, an automated tool for the detection and segmentation of tumors was trained and internally validated. The Dice similarity coefficient obtained for the independent validation dataset was 0.997, indicating compatibility with the manual segmentation variability. Following this, radiomics and deep features were extracted and correlated with clinical endpoints. Finally, reproducible and relevant imaging quantitative features were integrated with clinical and molecular data to enrich both the predictive models and a set of visual analytics tools, making the PRIMAGE platform a complete clinical decision aid system. In order to ensure the advancement of research in this field and to foster engagement with the wider research community, the PRIMAGE data repository and platform are currently being integrated into the European Federation for Cancer Images (EUCAIM), which is the largest European cancer imaging research infrastructure created to date.

来源:Pediatr Radiol,查看原文。版权归原作者所有。

引用

  1. Veiga-Canuto D, Cerdá Alberich L, Fernández-Patón M, et al. Imaging biomarkers and radiomics in pediatric oncology: a view from the PRIMAGE (PRedictive In silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers) project. Pediatr Radiol. 2023. PMID: 37747582. doi:10.1007/s00247-023-05770-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。